Moffitt logo

Clinical Trials Search

Clinical Trial 21097

Cancer Type: Multiple
Study Type: Treatment
NCT#: NCT04032704

Phase: Phase II
Principal Investigator:

Call 813-745-6100
or 1-800-679-0775 Learn More
Overview

Study Title

Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for Unresectable Locally Advanced or Metastatic Solid Tumors

Summary

Objective

Treatments

Therapies

Medications

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.